2/4/25 17:54 | 2/3/25 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S.d | -303 | 2.10 | 0 | -144 | -5 | 2,924 | D | | | | | | | | | | | | | | |
3/1/24 17:47 | 2/29/24 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S | -74 | 1.58 | 0 | -47 | -2 | 2,364 | D | | | | | | | | | | | | | | |
2/29/24 18:00 | 2/27/24 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S | -57 | 1.52 | 0 | -38 | -2 | 2,411 | D | | | | | | | | | | | | | | |
2/2/24 16:10 | 2/1/24 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S.d | -78 | 1.68 | 0 | -46 | -2 | 2,449 | D | | | | | | | | | | | | | | |
6/15/23 16:28 | 6/14/23 | ZYNE | Zynerba Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | PA | D | | S.d | 0 | 0.3481 | 0 | 0 | 0 | 81 | D | | | | | | | | | | | | | | |
3/3/23 08:01 | 3/1/23 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S | -81 | 0.8775 | 0 | -92 | -5 | 1,889 | D | | | | | | | | | | | | | | |
3/1/23 16:07 | 2/27/23 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S | -31 | 0.8132 | 0 | -39 | -2 | 1,981 | D | | | | | | | | | | | | | | |
6/16/22 21:48 | 6/14/22 | ZYNE | Zynerba Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | PA | D | | S.d | 0 | 1.01 | 0 | 0 | 0 | 33 | D | | | | | | | | | | | | | | |
3/2/22 21:25 | 2/28/22 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S.dm | -171 | 2.17 | 0 | -79 | -4 | 1,723 | D | | | | | | | | | | | | | | |
4/1/21 20:32 | 4/1/21 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S | -14 | 3.40 | 0 | -4 | 0 | 1,534 | D | | | | | | | | | | | | | | |
3/2/21 16:10 | 3/1/21 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | S.d | -170 | 3.40 | 0 | -50 | -3 | 1,499 | D | | | | | | | | | | | | | | |
6/8/16 17:19 | 6/7/16 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Butler John P. | CA | D | | S | -20 | 19.32 | 33 | -1 | -26 | 3 | D | -21 | -46 | -34 | 43 | 5 | 32 | 17 | -7 | -2 | 1 | 2 | | | |
6/15/15 18:40 | 6/11/15 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Butler John P. | CA | D | | S | -38 | 34.62 | 13 | -1 | -22 | 4 | D | | 44 | 7 | -16 | 12 | -1 | -4 | -3 | 0 | -1 | -6 | -28 | -18 | -43 |